文献速递骨肌介入CTDRDSA

经皮消融、骨成形、强化与内固定术治疗髋臼周围溶骨性恶性肿瘤的疼痛与行走功能

Percutaneous Ablation, Osteoplasty, Reinforcement, and Internal Fixation for Pain and Ambulatory Function in Periacetabular Osteolytic Malignancies.
PubMed 文献 · Radiology · 2023-03-14

这项回顾性观察研究纳入50例髋臼周围溶骨性转移瘤或多发性骨髓瘤患者,评估经皮消融、骨成形、强化与内固定(AORIF)的疗效。术后2周疼痛与行走功能综合指数从4.5±2.4改善至7.8±2.1(P<.001),ECOG评分中位数从3改善至1(P<.001),22例不能行走患者中19例首次术后随访即可行走。疼痛与功能改善维持超过1年,长达40个月,无硬件失败、手术部位感染、再入院或治疗延迟。

要点

  • AORIF术后2周疼痛与行走功能即显著改善,19/22例非行走患者恢复行走。
  • 疼痛与功能改善维持超过1年,长达40个月,无硬件失败或感染。
  • 12例髋臼内陷患者中仅1例在24个月时需转为半髋关节置换。

诊断标准与关键数值

  • 疼痛与行走功能综合指数评分范围1分(卧床)至10分(正常行走),术后2周平均分从4.5±2.4改善至7.8±2.1(P<.001)。
  • ECOG评分中位数从3(IQR 2-4)改善至1(IQR 1-2)(P<.001)。
  • 22例非行走患者中19例在首次术后随访时恢复行走。

临床应用与阅片要点

  • 对于髋臼周围溶骨性肿瘤导致疼痛和行走障碍的患者,AORIF可快速改善疼痛和行走功能,避免开放手术并发症。
  • 术后需系列X线和CT评估髋关节完整性,关注髋臼内陷患者需转换关节置换的风险。

局限性

  • 回顾性观察研究,样本量50例,非随机对照,可能存在选择偏倚。
  • 中位随访时间11个月(IQR 4-14个月),长期结局数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Osteolytic neoplasms to periacetabular bone frequently cause pain and fractures. Immediate recovery is integral to lifesaving ambulatory oncologic care and maintaining quality of life. Yet, open acetabular reconstructive surgeries are associated with numerous complications that delay cancer treatments. Purpose To determine the effectiveness for short- and long-term pain and ambulatory function following percutaneous ablation, osteoplasty, reinforcement, and internal fixation (AORIF) for periacetabular osteolytic neoplasm. Materials and Methods This retrospective observational study evaluated clinical data from 50 patients (mean age, 65 years ± 14 [SD]; 25 men, 25 women) with osteolytic periacetabular metastases or myeloma. The primary outcome of combined pain and ambulatory function index score (range, 1 [bedbound] through 10 [normal ambulation]) was assessed before and after AORIF at 2 weeks and then every 3 months up to 40 months (overall median follow-up, 11 months [IQR, 4-14 months]). Secondary outcomes included Eastern Cooperative Oncology Group (ECOG) score, infection, transfusion, 30-day readmission, mortality, and conversion hip arthroplasty. Serial radiographs and CT images were obtained to assess the hip joint integrity. The paired t test or Wilcoxon signed-rank test and Kaplan-Meier analysis were used to analyze data. Results Mean combined pain and ambulatory function index scores improved from 4.5 ± 2.4 to 7.8 ± 2.1 (P < .001) and median ECOG scores from 3 (IQR, 2-4) to 1 (IQR, 1-2) (P < .001) at the first 2 weeks after AORIF. Of 22 nonambulatory patients, 19 became ambulatory on their first post-AORIF visit. Pain and functional improvement were retained beyond 1 year, up to 40 months after AORIF in surviving patients. No hardware failures, surgical site infections, readmissions, or delays in care were identified following AORIF. Of 12 patients with protrusio acetabuli, one patient required a conversion hemiarthroplasty at 24 months. Conclusion The ablation, osteoplasty, reinforcement, and internal fixation, or AORIF, technique was effective for short- and long-term improvement of pain and ambulatory function in patients with periacetabular osteolytic neoplasm. © RSNA, 2023.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Dussik, Toombs, Alder, et al. Percutaneous Ablation, Osteoplasty, Reinforcement, and Internal Fixation for Pain and Ambulatory Function in Periacetabular Osteolytic Malignancies. Radiology. 2023. PMID: 36916888. doi:10.1148/radiol.221401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。